Editorial: Primary membranous nephropathy
Frontiers in Immunology, 2022 Maria Infantino
doaj +3 more sources
Penicillamine-Induced Membranous Nephropathy in an Adolescent with Wilson’s Disease [PDF]
Revista Portuguesa de Nefrologia e Hipertensão, 2022 Membranous nephropathy may present in any age group. While it is one of the most common causes of adult nephrotic syndrome, it is a rare histologic entity in the paediatric population.
Catarina Fernandes +5 more
doaj +3 more sources
Evolution of chronic glomerular disease spectrum and epidemiological characteristics of membranous nephropathy [PDF]
Linchuang shenzangbing zazhi, 2019 Objective To investigate the composition of chronic glomerular disease spectrum as well as the epidemiological characteristics of membranous nephropathy in Guangdong Provincial People’s Hospital in recent 18 years.
XIE Zhi-yong +10 more
doaj +1 more source
Primary Membranous Nephropathy as a Model of Autoimmune Disease [PDF]
, 2019 Membranous nephropathy is the most common cause of adult nephrotic syndrome worldwide with a significant health care burden. There has been a leap in our understanding of the disease mechanism over the last decade with a remarkably strong genetic component to the development of the disease and its strong association with high affinity antibody—in the ...
Hamilton, Patrick +2 more
openaire +3 more sources
Advances in the pathogenesis and clinical applications of PLA2R-associated membranous nephropathy [PDF]
Linchuang shenzangbing zazhiMembranous nephropathy is one of the main pathological types of nephrotic syndrome. PLA2R（phospholipase A2 receptor）associated membranous nephropathy is the predominant type of primary membranous nephropathy， also known as idiopathic membranous ...
Sun Miao-xin +9 more
doaj +2 more sources
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach [PDF]
BMC Nephrology, 2023 Background The currently recommended dose of rituximab for primary membranous nephropathy is as high as that for lymphoma. However, the clinical manifestations of membranous nephropathy vary widely.
Song Wang +6 more
doaj +2 more sources
Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy [PDF]
International Journal of Nephrology, 2013 Background. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy.
Claire Kennedy +4 more
doaj +2 more sources
Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy. [PDF]
Kidney Int RepPovetacicept is an inhibitor of B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), 2 cytokines central to the pathogenesis of autoimmune glomerulonephritis. Both BAFF and APRIL promote B-cell and plasma cell survival and function.
Madan A +16 more
europepmc +4 more sources
Contemporary review of primary membranous nephropathy
Frontiers in ImmunologyPrimary membranous nephropathy (PMN) is a single-organ autoimmune disease caused by autoantibodies targeting podocyte-associated antigens, most commonly phospholipase A2-receptor (PLA2R).
Edward J. Filippone, John L. Farber
doaj +2 more sources
Anti Phospholipase A2 Receptor 1 Antibodies and Membranous Nephropathy Recurrence After Kidney Transplantation [PDF]
Kidney International ReportsIntroduction: Membranous nephropathy can lead to end-stage kidney disease, for which kidney transplantation is the preferred therapy. However, the disease often relapses, which can impact allograft survival.
Marion Cremoni +35 more
doaj +2 more sources